Determinants of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol Pharmacokinetics in a Cohort of Tuberculosis Patients

समान संसाधन

• Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIV
  द्वारा: Abdelwahab, Mahmoud Tareq, और अन्य
  प्रकाशित: (2020)
• Pharmacokinetics of Rifampin, Isoniazid, Pyrazinamide, and Ethambutol in Infants Dosed According to Revised WHO-Recommended Treatment Guidelines
  द्वारा: Bekker, A., और अन्य
  प्रकाशित: (2016)
• Isoniazid, Rifampin, Ethambutol and Pyrazinamide Pharmacokinetics and Treatment Outcomes among a Predominantly HIV-Infected Cohort of Adults with Tuberculosis — Botswana
  द्वारा: Chideya, Sekai, और अन्य
  प्रकाशित: (2009)
• Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania
  द्वारा: Denti, Paolo, और अन्य
  प्रकाशित: (2015)
• HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients
  द्वारा: Rockwood, Neesha, और अन्य
  प्रकाशित: (2016)